Andina Acquisition Corp. III 10-Q 14 Apr 17 2017 Q1 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	3 Months Ended
	Feb. 28, 2017	Apr. 14, 2017
Document And Entity Information
Entity Registrant Name	Andina Acquisition Corp. II
Entity Central Index Key	1,652,101
Document Type	10-Q
Document Period End Date	Feb. 28, 2017
Amendment Flag	false
Current Fiscal Year End Date	--11-30
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		5,310,000
Trading Symbol	ANDAU
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2,017

Condensed Balance Sheets

Condensed Balance Sheets - USD ($)	Feb. 28, 2017	Nov. 30, 2016
Current assets
Cash	$ 27,823	$ 63,789
Prepaid expenses	297,929	259,053
Other receivable	5,839
Total current assets	331,591	322,842
Cash and marketable securities held in Trust Account	40,611,976	40,651,426
Total assets	40,943,567	40,974,268
Liabilities and Shareholders' Equity
Accrued expenses	59,678	2,166
Accounts payable	62,794	18,944
Total current liabilities	122,472	21,110
Commitments
Ordinary shares subject to possible conversion, $0.0001 par value, 3,528,131 and 3,537,686 shares at conversion value at February 28, 2017 and November 30, 2016, respectively	35,821,093	35,953,149
Shareholders' Equity:
Preferred shares, $0.0001 par value; 1,000,000 shares authorized; no shares issued and outstanding at February 28, 2017 and November 30, 2016
Ordinary shares, $0.0001 par value, 100,000,000 shares authorized; 1,781,869 and 1,772,314 shares issued and outstanding at February 28, 2017 and November 30, 2016, respectively (excluding 3,528,131 and 3,537,686 shares subject to possible conversion at February 28, 2017 and November 30, 2016, respectively)	178	177
Additional paid-in capital	5,548,831	5,416,776
Accumulated deficit	(549,007)	(416,944)
Total shareholders' equity	5,000,002	5,000,009
Total Liabilities and Shareholders' Equity	$ 40,943,567	$ 40,974,268

Condensed Balance Sheets (Paren

Condensed Balance Sheets (Parenthetical) - $ / shares	Feb. 28, 2017	Nov. 30, 2016
Statement of Financial Position [Abstract]
Ordinary shares subject to conversion, par value	$ 0.0001	$ 0.0001
Ordinary shares subject to conversion	3,528,131	3,537,686
Preferred shares, par value	$ 0.0001	$ 0.0001
Preferred shares, authorized	1,000,000	1,000,000
Preferred shares, issued
Preferred shares, outstanding
Ordinary shares, par value	$ 0.0001	$ 0.0001
Ordinary shares, authorized	100,000,000	100,000,000
Ordinary shares, issued	1,781,869	1,772,314
Ordinary shares, outstanding	1,781,869	1,772,314

Statements of Operations (Unaud

Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Feb. 28, 2017	Feb. 29, 2016
Income Statement [Abstract]
General and administrative	$ 178,588	$ 189,657
Loss from operations	(178,588)	(189,657)
Interest income	46,525	67,527
Net loss	$ (132,063)	$ (122,130)
Weighted average shares outstanding, basic and diluted	1,772,420	1,732,527
Basic and diluted net loss per ordinary share	$ (0.07)	$ (0.07)

Statement of Cash Flows (Unaudi

Statement of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Feb. 28, 2017	Feb. 29, 2016
Cash Flows from Operating Activities
Net loss	$ (132,063)	$ (122,130)
Adjustments to reconcile net loss to net cash used in operation activities:
Interest earned on cash and marketable securities held in Trust Account	(46,523)	(67,518)
Changes in operating assets and liabilities:
Prepaid expenses	(38,876)	(332,589)
Other receivable	(5,839)
Accrued expenses	57,512	(207,184)
Accounts payable	43,850	(86,823)
Net cash used in operating activities	(121,939)	(816,244)
Cash Flows from Investing Activities
Principal deposited in Trust Account		(40,600,000)
Interest released from Trust Account	85,973
Net cash provided by (used in) investing activities	85,973	(40,600,000)
Cash Flows from Financing Activities
Proceeds from initial public offering, net of costs		38,699,151
Proceeds from private placement		3,100,000
Repayment of advance from related party		(139,172)
Net cash provided by financing activities		41,659,979
Net change in cash	(35,966)	243,735
Cash - beginning of the period	63,789	100
Cash - ending of the period	27,823	243,835
Supplemental disclosure of noncash investing and financing activities:
Reclassification of deferred offering costs to equity		454,149
Initial value of ordinary shares subject to possible conversion		36,313,487
Change in value of ordinary shares subject to possible conversion	$ (132,056)	$ (123,349)

Organization, Plan of Business

Organization, Plan of Business Operations	3 Months Ended
	Feb. 28, 2017
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization, Plan of Business Operations	Note 1 - Organization, Plan of Business Operations Andina Acquisition Corp. II (the “Company”) was incorporated in the Cayman Islands on July 1, 2015 as a blank check company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities (a “Business Combination”). The Company’s efforts to identify a prospective target business are not limited to a particular industry or geographic region, although the Company is currently focusing on target businesses in the Andean region of South America and in Central America. All activity through February 28, 2017 relates to the Company’s formation, the initial public offering described below and the search for a Business Combination candidate. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies. The registration statement for the Company’s initial public offering (“Initial Public Offering”) was declared effective on November 24, 2015. The Company consummated the Initial Public Offering of 4,000,000 units (“Units”) at $10.00 per unit on December 1, 2015, generating gross proceeds of $40.0 million. Offering costs were approximately $1.8 million, inclusive of $454,000 of deferred offering costs incurred prior to the closing of the Initial Public Offering (Note 4). Simultaneously with the closing of the Initial Public Offering, the Company consummated the private placement (“Private Placement”) of 310,000 Units (“Private Placement Units”) at a price of $10.00 per Private Placement Unit, of which 265,000 Private Placement Units were sold to certain shareholders of the Company and their affiliates and designees, and 45,000 Private Placement Units were sold to EarlyBirdCapital, Inc. (“EBC”), the representative of the underwriters in the Initial Public Offering, generating gross proceeds of $3.1 million (Note 5). The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and Private Placement, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. An aggregate amount of $40.6 million ($10.15 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the Private Placement Units in the Private Placement was placed in a United States-based trust account (“Trust Account”) at UBS maintained by Continental Stock Transfer & Trust Company, acting as trustee, and is invested in U.S. government treasury bills, until the earlier of: (i) the consummation of a Business Combination or (ii) the Company’s failure to consummate a Business Combination by June 1, 2017 (or September 1, 2017 if the Company has entered into a letter of intent, memorandum of understanding or definitive agreement with a target business for a Business Combination by June 1, 2017 and a Business Combination has not yet been consummated by such date). One of the Company’s Directors has agreed that he will be liable under certain circumstances to ensure that the proceeds in the Trust Account are not reduced by the claims of target businesses or vendors or other entities that are owed money by the Company for services rendered, contracted for or products sold to the Company and that have not executed a waiver agreement with the Company. However, such Director may not be able to satisfy those obligations should they arise. The remaining net proceeds (not held in the Trust Account) may be used to pay for business, legal and accounting due diligence on prospective Business Combinations and continuing general and administrative expenses. In addition, (i) interest income earned on the funds in the Trust Account may be released to the Company to pay its income or other tax obligations and (ii) any remaining interest earned on the funds in the Trust Account may be released to the Company for its working capital requirements. With these exceptions, expenses incurred by the Company may be paid prior to a Business Combination only from the net proceeds of the Initial Public Offering and Private Placement not held in the Trust Account; provided, however, that in order to meet its working capital needs, the Company’s shareholders prior to the Initial Public Offering (the “Initial Shareholders”), officers and directors or their affiliates may, but are not obligated to, loan the Company funds, from time to time or at any time, in whatever amount they deem reasonable in their sole discretion. Each loan would be evidenced by a promissory note. The notes would either be paid upon consummation of the Company’s initial Business Combination, without interest, or, at the lender’s discretion, up to $500,000 of the notes may be converted upon consummation of the Company’s Business Combination into additional Private Placement Units at a price of $10.00 per Private Placement Unit. If the Company does not complete a Business Combination, the loans would not be repaid. Pursuant to the Nasdaq Capital Markets listing rules, the Company’s initial Business Combination must be with a target business or businesses whose collective fair market value is at least equal to 80% of the balance in the Trust Account (excluding taxes payable) at the time of the execution of a definitive agreement for such Business Combination, although this may entail simultaneous acquisitions of several target businesses. The fair market value of the target will be determined by the Company’s board of directors based upon one or more standards generally accepted by the financial community (such as actual and potential sales, earnings, cash flow and/or book value). The target business or businesses that the Company acquires may have a collective fair market value substantially in excess of 80% of the Trust Account balance. In order to consummate such a Business Combination, the Company may issue a significant amount of its debt or equity securities to the sellers of such business and/or seek to raise additional funds through a private offering of debt or equity securities. In connection with any proposed initial Business Combination, the Company will either (1) seek shareholder approval of such initial Business Combination at a meeting called for such purpose at which holders of the outstanding ordinary shares sold in the Initial Public Offering (“Public Shareholders”) may seek to convert such shares (“Public Shares”), regardless of whether they vote for or against the proposed Business Combination, into their pro rata share of the aggregate amount then on deposit in the Trust Account (net of taxes payable) or (2) provide Public Shareholders with the opportunity to sell their Public Shares to the Company by means of a tender offer (and thereby avoid the need for a shareholder vote) for an amount equal to their pro rata share of the aggregate amount then on deposit in the Trust Account (net of taxes payable). As of February 28, 2017, the amount in the Trust Account is $10.15 per Public Share (excluding interest in the amount of approximately $12,000 that may be released to the Company as described above). If the Company determines to engage in a tender offer, such tender offer will be structured so that each Public Shareholder may tender any or all of his, her or its Public Shares rather than some pro rata portion of his, her or its shares. In that case, the Company will file tender offer documents with the Securities and Exchange Commission (“SEC”) which will contain substantially the same financial and other information about the initial Business Combination as is required under the SEC’s proxy rules. The decision as to whether the Company will seek shareholder approval of a proposed Business Combination or will allow shareholders to sell their shares to it in a tender offer will be made by the Company based on a variety of factors such as the timing of the transaction and whether the terms of the transaction would otherwise require it to seek shareholder approval. The Company will consummate an initial Business Combination only if it has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and, solely if it seeks shareholder approval, a majority of the outstanding ordinary shares voted are voted in favor of the Business Combination. The Initial Shareholders have agreed to certain obligations and restrictions relating to their securities, including to vote in favor of any proposed Business Combination and in certain cases not to convert any shares in connection with a shareholder vote to approve, or sell their shares to the Company in any tender offer in connection with, a proposed initial Business Combination (See Note 6). The Representative has also agreed to vote its shares included in the Private Placement Units (the “private shares”) in favor of any proposed Business Combination. Notwithstanding the foregoing, a Public Shareholder, together with any affiliate of his or any other person with whom he is acting in concert or as a “group” (as defined in Section 13(d)(3) of the Securities Exchange Act of 1934, as amended (“Exchange Act”) will be restricted from seeking conversion rights with respect to 20% or more of the ordinary shares sold in the Initial Public Offering without the prior consent of the Company. Accordingly, all shares in excess of 20% of the shares sold in the Initial Public Offering held by a holder will not be converted to cash. The Company’s Amended and Restated Memorandum and Articles of Association currently provides that the Company will continue in existence only until June 1, 2017 (or September 1, 2017 if the Company has entered into a letter of intent, memorandum of understanding or definitive agreement with a target business for a Business Combination by June 1, 2017 and a Business Combination has not yet been consummated by such date). If the Company has not completed a Business Combination by such date, it will trigger the automatic liquidation of the Trust Account and the voluntary liquidation of the Company. In such event, holders of Public Shares will share ratably in the Trust Account, including any interest not previously released to the Company, and any net assets remaining available for distribution to them after payment of liabilities. The Representative and the holders of the insider shares (as defined in Note 5), private shares, and rights and warrants included in the Private Placement Units (the “private rights” and “private warrants” respectively) will not participate in any liquidation distribution with respect to their insider shares, private shares, private rights or private warrants.

Basis of Presentation

Basis of Presentation	3 Months Ended
	Feb. 28, 2017
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	Note 2 - Basis of Presentation The accompanying unaudited condensed financial statements have been prepared in accordance with United States generally accepted accounting principles (“U.S. GAAP”) for interim financial information and pursuant to rules and regulations of the SEC. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP. In the opinion of management, all adjustments (consisting of normal accruals) considered for a fair presentation have been included. Operating results for the three months ended February 28, 2017 are not necessarily indicative of the results that may be expected for the year ending November 30, 2017. For further information, refer to the financial statements and footnotes thereto included in the Company’s Annual Report on Form 10-K for the year ended November 30, 2016, filed with SEC on February 28, 2017. Liquidity As of February 28, 2017, the Company had approximately $28,000 in its operating bank account, approximately $12,000 of interest income held in the Trust Account available to be released to the Company. Through February 28, 2017, the Company’s liquidity needs were satisfied through receipt of approximately $686,000 from the sale of the Units held outside of the Trust Account upon closing of the Initial Public Offering, $25,000 from the sale of the insider shares (as described in Note 6), advances from a director in an aggregate amount of $139,000, which was repaid on December 1, 2015 from the proceeds received upon closing of the Initial Public Offering, and interest released from the Trust Account for working capital purposes. As indicated above, if needed to finance transaction costs in connection with searching for a target business or consummating an intended initial Business Combination, the Initial Shareholders, officers, directors or their affiliates may, but are not obligated to, loan the Company funds as may be required. Such loans would be evidenced by promissory notes. The notes would either be paid upon consummation of the Company’s initial Business Combination, without interest, or, at the lender’s discretion, up to $500,000 of the notes may be converted upon consummation of the Company’s initial Business Combination into additional Private Placement Units at a price of $10.00 per Unit (which, for example, would result in the holders being issued 57,142 Ordinary Shares if $500,000 of notes were so converted as the rights included in the Units would result in an additional 7,142 shares being issued, as well as 50,000 Warrants to purchase 25,000 Ordinary Shares). In February 2017, one of the Company’s directors and non-executive Chairman of the Board provided a commitment letter, which was later amended in April 2017, to loan the Company as needed up to an aggregate of $110,000 for working capital purposes. To date, the Company has not borrowed any amount under such commitment. Based on the foregoing, management believes that the Company will have sufficient working capital to meet the Company’s needs through the earlier of the consummation of a Business Combination or June 1, 2017 (or September 1, 2017 if the Company has entered into a letter of intent, memorandum of understanding or definitive agreement with a target business for a business combination by June 1, 2017 and a business combination has not yet been consummated by such date). The Company anticipates that its uses of cash until September 1, 2017 will be approximately $228,000 of expenses for the search for target businesses and for the legal, accounting and other third-party expenses attendant to the due diligence investigations, structuring and negotiating of a Business Combination.

Significant Accounting Policies

Significant Accounting Policies	3 Months Ended
	Feb. 28, 2017
Accounting Policies [Abstract]
Significant Accounting Policies	Note 3 - Significant Accounting Policies Emerging Growth Company Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a registration statement under the Securities Act of 1933, as amended (“Securities Act”), declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. Cash and Cash Equivalents The Company considers all short-term investments with a maturity of three months or less when purchased to be cash equivalents. Concentration of Credit Risk Financial instruments that potentially subject the Company to concentration of credit risk consist of cash accounts in a financial institution which, at times may exceed the Federal depository insurance coverage of $250,000. At February 28, 2017, the Company had not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature. Cash and Marketable Securities Held in Trust Account The amounts held in the Trust Account represent substantially all of the proceeds of the Initial Public Offering and are classified as restricted assets since such amounts can only be used by the Company in connection with the consummation of a Business Combination. As of February 28, 2017, cash and cash equivalents held in the Trust Account consisted of approximately $40.6 million in United States Treasury Bills and approximately $630 in cash. At February 28, 2017, there was approximately $12,000 of interest income held in the Trust Account available to be released to the Company. Ordinary Shares Subject to Possible Conversion The Company accounts for its Ordinary Shares subject to possible conversion in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Ordinary Shares subject to mandatory redemption (if any) are classified as a liability instrument and are measured at fair value. Conditionally redeemable Ordinary Shares (including Ordinary Shares that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Ordinary Shares are classified as shareholders’ equity. The Company’s Ordinary Shares features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, Ordinary Shares subject to possible conversion at conversion value are presented as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet. Net Loss per Share Loss per share is computed by dividing net loss by the weighted-average number of Ordinary Shares outstanding during the period. An aggregate of 3,528,131 and 3,558,519 Ordinary Shares subject to possible redemption for the three months ended February 28, 2017 and February 29, 2016, respectively, have been excluded from the calculation of basic loss per ordinary share since such Ordinary Shares, if redeemed, only participate in their pro rata share of the trust earnings. The Company has not considered the effect of (i) warrants sold in the Public Offering and Private Placement to purchase 2,155,000 Ordinary Shares of the Company, (ii) rights to acquire 615,713 Ordinary Shares of the Company and (iii) 400,000 Ordinary Shares, warrants to purchase 200,000 Ordinary Shares and rights to acquire 57,142 Ordinary Shares included in the unit purchase option sold to the underwriter, in the calculation of diluted loss per share, since the exercise of the unit purchase option and warrants as well as the conversion of rights is contingent on the occurrence of future events. Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. Actual results could differ from those estimates. Recent Accounting Standards Management does not believe that any recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying financial statements.

Initial Public Offering

Initial Public Offering	3 Months Ended
	Feb. 28, 2017
Equity [Abstract]
Initial Public Offering	Note 4 - Initial Public Offering On December 1, 2015, the Company consummated the Initial Public Offering of 4,000,000 Units. The Units were sold at an offering price of $10.00 per Unit, generating net proceeds of approximately $38.2 million, net of offering costs of approximately $1.8 million, inclusive of $454,000 of deferred offering costs incurred prior to the closing of the Initial Public Offering. Each Unit consists of one ordinary share in the Company, one right to receive one-seventh (1/7) of a share upon consummation of an initial Business Combination and one redeemable warrant (“Warrant”) to purchase one half of one ordinary share for $11.50 per full share. No fractional shares will be issued. In the event the Company will not be the surviving company upon completion of an initial Business Combination, each holder of a right will be required to affirmatively convert his, her or its rights in order to receive the 1/7 of a share underlying each right upon consummation of the Business Combination. There is no length of time within which an investor must affirmatively elect to convert the rights. However, until a holder affirmatively elects to convert his, her or its rights, the right certificates held by such holder will not represent the ordinary shares they are convertible for but instead will simply represent the right to receive such ordinary shares. Each Warrant entitles the holder to purchase one-half of one ordinary share at a price of $11.50 per full ordinary share commencing on the Company’s completion of its initial Business Combination, and expiring five years from the completion of the Company’s initial Business Combination. The Company will not issue fractional shares. As a result, investors must exercise Warrants in multiples of two Warrants, at a price of $11.50 per full share, subject to adjustment, to validly exercise the Warrants. The Company may redeem the Warrants at a price of $0.01 per Warrant upon 30 days’ notice, only in the event that the last sale price of the ordinary shares is at least $24.00 per share for any 20 trading days within a 30-trading day period (“30-Day Trading Period”) ending on the third day prior to the date on which notice of redemption is given, provided there is a current registration statement in effect with respect to the ordinary shares underlying such Warrants commencing five business days prior to the 30-Day Trading Period and continuing each day thereafter until the date of redemption. If the Company redeems the Warrants as described above, management will have the option to require all holders that wish to exercise Warrants to do so on a “cashless basis.” In accordance with the warrant agreement relating to the Warrants sold and issued in the Initial Public Offering the Company is only required to use its best efforts to maintain the effectiveness of the registration statement covering the Warrants. If a registration statement is not effective within 90 days following the consummation of a Business Combination, Warrant holders may, until such time as there is an effective registration statement and during any period when the Company shall have failed to maintain an effective registration statement, exercise Warrants on a cashless basis pursuant to an available exemption from registration under the Securities Act. In the event that a registration statement is not effective at the time of exercise or no exemption is available for a cashless exercise, the holder of such Warrant shall not be entitled to exercise such Warrant for cash and in no event (whether in the case of a registration statement being effective or otherwise) will the Company be required to net cash settle the Warrant exercise. Additionally, in no event will the Company be required to net cash settle the Rights. If the Company is unable to complete an initial Business Combination within the required time period and the Company redeems the Public Shares for the funds held in the Trust Account, holders of rights and warrants will not receive any of such funds for their rights and warrants and the rights and warrants will expire worthless.

Private Placement

Private Placement	3 Months Ended
	Feb. 28, 2017
Equity [Abstract]
Private Placement	Note 5 - Private Placement Simultaneously with the consummation of the Initial Public Offering, the Company consummated the Private Placement of 310,000 Private Placement Units, at $10.00 per Private Placement Unit for a total purchase price of $3.1 million. Of the Private Placement Units, 265,000 were purchased by Initial Shareholders and their affiliates and designees and 45,000 were purchased by EBC. The Private Placement Units are identical to the units sold in the Initial Public Offering except the warrants included in the Private Placement Units are non-redeemable and may be exercised on a cashless basis, in each case so long as they continue to be held by the initial purchasers or their permitted transferees. Additionally, because the warrants included in the Private Placement Units were issued in a private transaction, the holders and their transferees will be allowed to exercise such warrants for cash even if a registration statement covering the ordinary shares issuable upon exercise of such warrants is not effective and receive unregistered ordinary shares. Furthermore, the purchasers have agreed (A) to vote the private shares in favor of any proposed Business Combination, (B) not to propose, or vote in favor of, an amendment to the Company’s proposed amended and restated memorandum and articles of association to be effected prior to the completion of the Initial Public Offering with respect to its pre-Business Combination activities prior to the consummation of such a Business Combination unless the Company provides dissenting Public Shareholders with the opportunity to convert their Public Shares in connection with any such vote, (C) not to convert any private shares for cash from the Trust Account in connection with a shareholder vote to approve a proposed initial Business Combination (or to sell such shares to the Company in any tender offer the Company may engage in) or a vote to amend the provisions of the Company’s amended and restated memorandum and articles of association relating to shareholders’ rights or pre-Business Combination activity and (D) that the private shares shall not participate in any liquidating distribution upon winding up if a Business Combination is not consummated. The purchasers have also agreed not to transfer, assign or sell any of the Private Units or underlying securities (except to certain permitted transferees) until the completion of an initial Business Combination.

Related Party Transactions

Related Party Transactions	3 Months Ended
	Feb. 28, 2017
Related Party Transactions [Abstract]
Related Party Transactions	Note 6 - Related Party Transactions Initial Shares In July 2015, the Company issued 1,150,000 ordinary shares (the “insider shares”) to the Initial Shareholders for an aggregate purchase price of $25,000. The insider shares held by the Initial Shareholders included an aggregate of 150,000 shares repurchased for an aggregate purchase price of $0.01 and cancelled by the Company in December 2015 upon receiving notice that the underwriters’ over-allotment option was not exercised in full. The insider shares are identical to the ordinary shares included in the Units sold in the Initial Public Offering. However, the Initial Shareholders have agreed (subject to certain exceptions) (A) to vote their insider shares (as well as any public shares acquired in or after the Initial Public Offering) in favor of any proposed Business Combination, (B) not to propose, or vote in favor of, an amendment to the amended and restated memorandum and articles of association with respect to pre-Business Combination activities prior to the consummation of such a Business Combination unless the Company provides dissenting public shareholders with the opportunity to convert their public shares into the right to receive cash from the trust account in connection with any such vote, (C) not to convert any insider shares (as well as any other shares acquired in or after the Initial Public Offering) into the right to receive cash from the Trust Account in connection with a shareholder vote to approve a proposed initial Business Combination (or sell any shares they hold to the Company in a tender offer in connection with a proposed initial Business Combination) or a vote to amend the provisions of the amended and restated memorandum and articles of association relating to shareholders’ rights or pre-Business Combination activity and (D) that the insider shares shall not participate in any liquidating distribution upon winding up if a business combination is not consummated. Additionally, the Initial Shareholders have agreed not to transfer, assign or sell any of the insider shares (except to certain permitted transferees) until (1) with respect to 50% of the insider shares, the earlier of one year after the date of the consummation of initial Business Combination and the date on which the closing price of ordinary shares equals or exceeds $12.50 per share (as adjusted for share splits, share dividends, reorganizations and recapitalizations) for any 20 trading days within any 30-trading day period commencing after initial business combination and (2) with respect to the remaining 50% of the insider shares, one year after the date of the consummation of initial Business Combination, or earlier, in either case, if, subsequent to initial business combination, the Company consummates a liquidation, merger, stock exchange or other similar transaction which results in all of shareholders having the right to exchange their ordinary shares for cash, securities or other property. Related Party Transactions Prior to the closing of the Initial Public Offering, a director has advanced an aggregate of approximately $139,000 to cover expenses related to the Company’s formation and the Initial Public Offering. The Company repaid this amount on December 1, 2015 from the proceeds received upon closing of the Initial Public Offering. In February 2017, one of the Company’s directors and non-executive Chairman of the Board provided a commitment letter, which was later amended in April 2017, to loan the Company up to an aggregate of $110,000 for working capital purposes. To date, the Company has not borrowed any amount under such commitment. The Company maintains its principal executive offices in office space provided to us at no cost by a third party affiliated with one of the Company’s directors. The Company is also permitted to pay consulting fees to its officers, directors, shareholders or their affiliates for assisting us in consummating our initial business combination in an amount not to exceed an aggregate of $500,000.

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Feb. 28, 2017
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Note 7 - Commitments and Contingencies Underwriting Agreement On November 24, 2015, the Company entered into an agreement with EBC (“Underwriting Agreement”), pursuant to which the Company paid an underwriting discount of $1.3 million. The Company has further engaged EBC to assist the Company with its initial Business Combination. Pursuant to this arrangement, the Company anticipates that EBC will assist the Company in holding meetings with shareholders to discuss the potential Business Combination and the target business’ attributes, introduce the Company to potential investors that are interested in purchasing the Company’s securities, assist the Company in obtaining shareholder approval for the Business Combination and assist the Company with its press releases and public filings in connection with the Business Combination. The Company will pay EBC a cash fee of $1,600,000 for such services upon the consummation of its initial Business Combination (exclusive of any applicable finders’ fees which might become payable); provided that up to 25% of the fee may be allocated at the Company’s sole discretion to one or more advisors that assist the Company in identifying and consummating an initial Business Combination. The Company will also reimburse EBC for up to $20,000 of its reasonable costs and expenses incurred by it (including reasonable fees and disbursements of counsel) in connection with the performance of its services pursuant to the agreement; provided, however, all expenses in excess of $5,000 in the aggregate shall be subject to prior written approval, which approval will not be unreasonably withheld. Unit Purchase Option In November 2015, the Company sold to EBC and its designees for $100, unit purchase options to purchase an aggregate of 400,000 units (collectively, the “Unit Purchase Option”). The Unit Purchase Option is exercisable at $10.00 per unit, commencing on the later of the consummation of a Business Combination and November 24, 2016. The Unit Purchase Option expires on November 24, 2020. Since the option is not exercisable until the consummation of a Business Combination at the earliest, and the rights will result in the issuance of shares upon consummation of a Business Combination, the option will effectively represent the right to purchase an aggregate 457,142 ordinary shares (which includes the 57,142 ordinary shares issuable for the rights included in the units, as well as 400,000 warrants to purchase 200,000 ordinary shares for $11.50 per share). The Unit Purchase Option grants to the holders demand and “piggy back” registration rights for periods of five and seven years, respectively, from November 24, 2015 with respect to the securities directly and indirectly issuable upon exercise of the option. The Company will bear all fees and expenses attendant to registering the securities, other than underwriting commissions which will be paid for by the holders themselves. The Company accounted for the fair value of the Unit Purchase Option, inclusive of the receipt of a $100 cash payment, as an expense of the Initial Public Offering resulting in a charge directly to shareholders’ equity. The Company estimated that the fair value of the Unit Purchase Option was approximately $2 million (or $5.01 per unit) using the Black-Scholes option-pricing model. The fair value of the Unit Purchase Option was estimated as of the date of grant using the following assumptions: (1) expected volatility of 57.71%, (2) risk-free interest rate of 1.52%, and (3) expected life of five years. The Unit Purchase Option may be exercised for cash or on a “cashless” basis, at the holder’s option, such that the holder may use the appreciated value of the Unit Purchase Option (the difference between the exercise prices of the Unit Purchase Option and the market price of the Units and underlying ordinary shares) to exercise the Unit Purchase Option without the payment of any cash. The Company will have no obligation to net cash settle the exercise of the Unit Purchase Option or underlying rights and warrants. Advisory Agreements On October 8, 2015, the Company engaged B. Riley & Co. LLC (“B. Riley”) to provide certain advisory services in connection with the Company’s initial Business Combination in exchange for $250,000 in service fees, which were paid in December 2015 and is included in Prepaid Expenses in the accompanying Condensed Balance Sheets as B. Riley has not provided material services to date. The Company has also signed agreements with individuals in the business community of their respective countries (the “Originators”) to supplement the efforts of the management team on its search of targets for a potential Business Combination. The agreements with the Originators are for a period of three to six months. In exchange for the services, the Company agreed to pay the Originators a finder’s fee of 0.75% of the transaction value, payable upon the completion of a Business Combination. The aggregated amount of the finders’ fee for the Financial Advisor and the Originators should be below 2.8% of the amount invested by the Company in the target company. To date, no fees have been incurred in connection with the agreements yet. Registration Rights The Initial Shareholders and purchasers of the private Placement Units are entitled to registration rights with respect to their securities, pursuant to an agreement dated as of November 24, 2015. The holders of the majority of the insider shares can elect to exercise these registration rights at any time commencing three months prior to the date on which these ordinary shares are to be released from escrow. The holders of a majority of the Private Placement Units (or underlying securities) issued in payment of working capital loans made to the Company can elect to exercise these registration rights at any time after the Company consummates a Business Combination. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the consummation of a Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

Shareholder Equity

Shareholder Equity	3 Months Ended
	Feb. 28, 2017
Equity [Abstract]
Shareholder Equity	Note 8 - Shareholder Equity Preferred Shares The Company is authorized to issue 1,000,000 preferred shares with a par value of $0.0001 per share with such designation, rights and preferences as may be determined from time to time by the Company’s board of directors. As of February 28, 2017, there are no preferred shares issued or outstanding. Ordinary Shares The Company is authorized to issue 100,000,000 ordinary shares with a par value of $0.0001 per share. As of February 28, 2017, after the consummation of the Initial Public Offering and the Private Placement, the Company has an aggregate of 5,310,000 ordinary shares outstanding, inclusive of 3,528,131 and 3,537,686 ordinary shares subject to possible conversion classified as temporary equity in the accompanying Balance Sheet as of February 28, 2017 and November 30, 2016, respectively.

Fair Value Measurements

Fair Value Measurements	3 Months Ended
	Feb. 28, 2017
Fair Value Disclosures [Abstract]
Fair Value Measurements	Note 9 - Fair Value Measurements The Company follows the guidance in ASC 820 for its financial assets and liabilities that are re-measured and reported at fair value at each reporting period, and non-financial assets and liabilities that are re-measured and reported at fair value at least annually. The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities: Level 1: Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. Level 2: Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. Level 3: Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability. The following table presents information about the Company’s assets that are measured on a recurring basis as of February 28, 2017, and November 30, 2016 and indicates the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value. Quoted Prices in Active Markets (Level 1) Description February 28, 2017 November 30, 2016 Cash and marketable securities held in Trust Account $ 40,611,976 40,651,426 Approximately $630 and $44,000 of the balance in the Trust Account was held in cash as of February 28, 2017 and November 30, 2016.

Subsequent Events

Subsequent Events	3 Months Ended
	Feb. 28, 2017
Subsequent Events [Abstract]
Subsequent Events	Note 10 - Subsequent Events The Company evaluates subsequent events and transactions that occur after the balance sheet date up to the date that the financial statements are filed for potential recognition or disclosure. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statements.

Significant Accounting Polici16

Significant Accounting Policies (Policies)	3 Months Ended
	Feb. 28, 2017
Accounting Policies [Abstract]
Emerging Growth Company	Emerging Growth Company Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a registration statement under the Securities Act of 1933, as amended (“Securities Act”), declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all short-term investments with a maturity of three months or less when purchased to be cash equivalents.
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentration of credit risk consist of cash accounts in a financial institution which, at times may exceed the Federal depository insurance coverage of $250,000. At February 28, 2017, the Company had not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature.
Cash and Marketable Securities Held in Trust Account	Cash and Marketable Securities Held in Trust Account The amounts held in the Trust Account represent substantially all of the proceeds of the Initial Public Offering and are classified as restricted assets since such amounts can only be used by the Company in connection with the consummation of a Business Combination. As of February 28, 2017, cash and cash equivalents held in the Trust Account consisted of approximately $40.6 million in United States Treasury Bills and approximately $630 in cash. At February 28, 2017, there was approximately $12,000 of interest income held in the Trust Account available to be released to the Company.
Ordinary Shares Subject to Possible Conversion	Ordinary Shares Subject to Possible Conversion The Company accounts for its Ordinary Shares subject to possible conversion in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Ordinary Shares subject to mandatory redemption (if any) are classified as a liability instrument and are measured at fair value. Conditionally redeemable Ordinary Shares (including Ordinary Shares that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Ordinary Shares are classified as shareholders’ equity. The Company’s Ordinary Shares features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, Ordinary Shares subject to possible conversion at conversion value are presented as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet.
Net Loss Per Share	Net Loss per Share Loss per share is computed by dividing net loss by the weighted-average number of Ordinary Shares outstanding during the period. An aggregate of 3,528,131 and 3,558,519 Ordinary Shares subject to possible redemption for the three months ended February 28, 2017 and February 29, 2016, respectively, have been excluded from the calculation of basic loss per ordinary share since such Ordinary Shares, if redeemed, only participate in their pro rata share of the trust earnings. The Company has not considered the effect of (i) warrants sold in the Public Offering and Private Placement to purchase 2,155,000 Ordinary Shares of the Company, (ii) rights to acquire 615,713 Ordinary Shares of the Company and (iii) 400,000 Ordinary Shares, warrants to purchase 200,000 Ordinary Shares and rights to acquire 57,142 Ordinary Shares included in the unit purchase option sold to the underwriter, in the calculation of diluted loss per share, since the exercise of the unit purchase option and warrants as well as the conversion of rights is contingent on the occurrence of future events.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. Actual results could differ from those estimates.
Recent Accounting Standards	Recent Accounting Standards Management does not believe that any recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying financial statements.

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	3 Months Ended
	Feb. 28, 2017
Fair Value Disclosures [Abstract]
Fair Value Assets Measured on Recurring Basis	The following table presents information about the Company’s assets that are measured on a recurring basis as of February 28, 2017, and November 30, 2016 and indicates the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value. Quoted Prices in Active Markets (Level 1) Description February 28, 2017 November 30, 2016 Cash and marketable securities held in Trust Account $ 40,611,976 40,651,426

Organization, Plan of Busines18

Organization, Plan of Business Operations (Details Narrative) - USD ($)	Dec. 02, 2015	Feb. 28, 2017
Unit price		$ 10
Amount held in trust		$ 10.15
Amount of net tangible assets for business combination		$ 5,000,001
Interest held in trust account available to release		$ 12,000
Description of conversion terms		All shares in excess of 20% of the shares sold in the Initial Public Offering held by a holder will not be converted to cash.
Initial Public Offering [Member]
Number of units issued	4,000,000
Unit price	$ 10
Gross proceeds from unit issued	$ 40,000,000
Net offering cost	1,800,000
Deferred offering costs	$ 454,000
Private Placement [Member]
Number of units issued		310,000
Unit price		$ 10
Gross proceeds from unit issued		$ 3,100,000
Maximum amount of notes converted		$ 500,000
Initial Shareholders [Member] | Private Placement [Member]
Number of units issued		265,000
Early Bird Capital [Member] | Private Placement [Member]
Number of units issued		45,000
Continental Stock Transfer & Trust Company [Member]
Unit price		$ 10.15
Total net proceeds placed in trust account		$ 40,600,000

Basis of Presentation (Details

Basis of Presentation (Details Narrative) - USD ($)	3 Months Ended
	Feb. 28, 2017	Nov. 30, 2016	Feb. 29, 2016	Dec. 02, 2015	Nov. 30, 2015
Cash balance	$ 27,823	$ 63,789	$ 243,835		$ 100
Interest income held in trust account available to release	12,000
Notes converted into units for initial business combination	$ 500,000
Unit price	$ 10
Ordinary shares issued	57,142
Ordinary shares issued in addition	7,142
Number of warrants issued	50,000
Warrants to purchase ordinary shares	25,000
Anticipated cash expenses for the next 12 months	$ 228,000
Directors and Non-Executive Chairman [Member]
Debt instrument face amount	110,000
Initial Public Offering [Member]
Proceeds held outside of the trust account	686,000
Number of shares issued upon new issue, value	25,000
Unit price				$ 10
Initial Public Offering [Member] | Director [Member]
Due to related party	139,000
Additional Private Placement Units [Member]
Notes converted into units for initial business combination	$ 500,000
Unit price	$ 10

Significant Accounting Polici20

Significant Accounting Policies (Details Narrative) - USD ($)	3 Months Ended
	Feb. 28, 2017	Nov. 30, 2016	Feb. 29, 2016
Federal depository insurance coverage	$ 250,000
Cash and cash equivalents held in the trust account	40,600,000
Cash	630
Interest income held in trust account available to release	$ 12,000
Ordinary shares subject to possible conversion	3,528,131	3,537,686	3,558,519
Initial Public Offering [Member]
Warrants sold in the public offering and private placement to purchase ordinary shares	2,155,000
Right to acquire of ordinary shares	615,713
Ordinary shares, included in the purchase option sold to the underwriter	400,000
Ordinary shares, warrants to purchase, included in the purchase option sold to the underwriter	200,000
Ordinary shares, rights to acquire, included in the purchase option sold to the underwriter	57,142

Initial Public Offering (Detail

Initial Public Offering (Details Narrative) - USD ($)	Dec. 02, 2015	Feb. 28, 2017
Class of Stock [Line Items]
Unit price		$ 10
Initial Public Offering [Member]
Class of Stock [Line Items]
Number of units issued	4,000,000
Unit price	$ 10
Net proceeds from unit issued	$ 38,200,000
Net offering cost	1,800,000
Deferred offering costs incurred prior to the closing of public offering	$ 454,000
Description of unit components		Each Unit consists of one ordinary share in the Company, one right to receive one-seventh (1/7) of a share upon consummation of an initial Business Combination and one redeemable warrant (“Warrant”) to purchase one half of one ordinary share for $11.50 per full share.
Warrants redeemable, threshold of stock price		$ 24
Warrants redeemable, threshold trading days		20 days
Redeemable Warrant [Member] | Initial Public Offering [Member]
Class of Stock [Line Items]
Exercise price		$ 11.50
Expiration period		5 years
Redemption price		$ 0.01

Private Placement (Details Narr

Private Placement (Details Narrative)	3 Months Ended
	Feb. 28, 2017USD ($)$ / sharesshares
Class of Stock [Line Items]
Unit price | $ / shares	$ 10
Private Placement [Member]
Class of Stock [Line Items]
Number of units issued	310,000
Unit price | $ / shares	$ 10
Net proceeds from unit issued | $	$ 31,000,000
Initial Shareholders [Member] | Private Placement [Member]
Class of Stock [Line Items]
Number of units issued	265,000
Early Bird Capital [Member] | Private Placement [Member]
Class of Stock [Line Items]
Number of units issued	45,000

Related Party Transactions (Det

Related Party Transactions (Details Narrative) - USD ($)	1 Months Ended		3 Months Ended
	Dec. 31, 2015	Jul. 31, 2015	Feb. 28, 2017	Dec. 02, 2015
Related Party Transaction [Line Items]
Share price			$ 10
Maximum allowable amount of consulting fees to its officers, directors, shareholders or their affiliates			$ 500,000
Initial Public Offering [Member]
Related Party Transaction [Line Items]
Number of shares issued upon new issue, value			25,000
Share price				$ 10
Initial Shareholders [Member]
Related Party Transaction [Line Items]
Number of shares issued upon new issue		1,150,000
Number of shares issued upon new issue, value		$ 25,000
Description of related party transaction		(1) with respect to 50% of the insider shares, the earlier of one year after the date of the consummation of initial Business Combination and the date on which the closing price of ordinary shares equals or exceeds $12.50 per share (as adjusted for share splits, share dividends, reorganizations and recapitalizations) for any 20 trading days within any 30-trading day period commencing after initial business combination and (2) with respect to the remaining 50% of the insider shares, one year after the date of the consummation of initial Business Combination, or earlier, in either case, if, subsequent to initial business combination, the Company consummates a liquidation, merger, stock exchange or other similar transaction which results in all of shareholders having the right to exchange their ordinary shares for cash, securities or other property.
Initial Shareholders [Member] | Over-Allotment Option [Member]
Related Party Transaction [Line Items]
Number of shares repurchased	150,000
Share price	$ 0.01
Director [Member] | Initial Public Offering [Member]
Related Party Transaction [Line Items]
Due to related party			139,000
Directors and Non-Executive Chairman [Member] | Initial Public Offering [Member]
Related Party Transaction [Line Items]
Working capital			$ 110,000

Commitments and Contingencies (

Commitments and Contingencies (Details Narrative) - USD ($)	Dec. 02, 2015	Nov. 24, 2015	Dec. 31, 2015	Feb. 28, 2017
Loss Contingencies [Line Items]
Number of ordinary shares called				25,000
Cash payment				$ 630
Description of commitments after completion of business combination				In exchange for the services, the Company agreed to pay the Originators a finder’s fee of 0.75% of the transaction value, payable upon the completion of a Business Combination.
Initial Public Offering [Member]
Loss Contingencies [Line Items]
Number of unit issued	4,000,000
Redeemable Warrant [Member] | Initial Public Offering [Member]
Loss Contingencies [Line Items]
Exercise price				$ 11.50
Minimum [Member]
Loss Contingencies [Line Items]
Agreement period				3 months
Maximum [Member]
Loss Contingencies [Line Items]
Agreement period				6 months
Finder's fee percentage, maximum				2.80%
Stock Option (Unit Purchase Option) [Member] | Underwriting Agreement [Member]
Loss Contingencies [Line Items]
Exercisable unit price				$ 10
Maturity date				Nov. 24, 2020
Aggregate number of ordinary shares				457,142
Number of rights called				57,142
Cash payment				$ 100
Estimate fair value				$ 2,000,000
Estimate fair value				$ 5.01
Expected volatility				57.71%
Risk-free interest rate				1.52%
Expected life				5 years
Stock Option (Unit Purchase Option) [Member] | Redeemable Warrant [Member] | Underwriting Agreement [Member]
Loss Contingencies [Line Items]
Number of rights called				400,000
Number of ordinary shares called				200,000
Exercise price				$ 11.50
Early Bird Capital [Member] | Underwriting Agreement [Member]
Loss Contingencies [Line Items]
Underwriting fees		$ 1,300,000
Payment of services for cash fee		$ 1,600,000
Percentage of finders' fee		25.00%
Reimbursement of reasonable fees and disbursements, maximum		$ 20,000
Description of restriction on reimbursement of reasonable fees and disbursements		All expenses in excess of $5,000 in the aggregate shall be subject to prior written approval, which approval will not be unreasonably withheld.
Early Bird Capital [Member] | Stock Option (Unit Purchase Option) [Member] | Underwriting Agreement [Member]
Loss Contingencies [Line Items]
Unit purchase option price				$ 100
Number of unit issued				400,000
B. Riley & Co. LLC [Member] | Initial Public Offering [Member]
Loss Contingencies [Line Items]
Cash payment for advisory services			$ 250,000

Shareholder Equity (Details Nar

Shareholder Equity (Details Narrative) - $ / shares	Feb. 28, 2017	Nov. 30, 2016	Feb. 29, 2016
Class of Stock [Line Items]
Preferred shares, authorized	1,000,000	1,000,000
Preferred shares, par value	$ 0.0001	$ 0.0001
Preferred shares, issued
Preferred shares, outstanding
Ordinary shares, authorized	100,000,000	100,000,000
Ordinary shares, par value	$ 0.0001	$ 0.0001
Share price	$ 10
Ordinary shares, outstanding	1,781,869	1,772,314
Ordinary shares subject to conversion	3,528,131	3,537,686	3,558,519
Initial Public Offering and Private Placement [Member]
Class of Stock [Line Items]
Ordinary shares, outstanding	5,310,000

Fair Value Measurements (Detail

Fair Value Measurements (Details Narrative) - USD ($)	Feb. 28, 2017	Nov. 30, 2016
Fair Value Disclosures [Abstract]
Fair value of assets, cash held in Trust Account	$ 630	$ 44,000

Fair Value Measurements - Fair

Fair Value Measurements - Fair Value Assets Measured on Recurring Basis (Details) - USD ($)	Feb. 28, 2017	Nov. 30, 2016
Cash and marketable securities held in Trust Account	$ 630	$ 44,000
Level 1 [Member]
Cash and marketable securities held in Trust Account	$ 40,611,976	$ 40,651,426